Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Anas Alawawdeh, Tharani Krishnan, Amitesh Roy, Christos Karapetis, Rohit Joshi, Nimit Singhal & Timothy Price. (2021) Curative therapy for rectal cancer. Expert Review of Anticancer Therapy 21:2, pages 193-203.
Read now
Read now
Andrew V Stachulski, M Gabriella Santoro, Sara Piacentini, Giuseppe Belardo, Simone La Frazia, Chandrakala Pidathala, Eleanor C Row, Neil G Berry, Mazhar Iqbal, Sarah A Allman, J Edward Semple, Brian M Eklov, Paul M O'Neill & Jean-Francois Rossignol. (2018) Second-Generation Nitazoxanide Derivatives: Thiazolides are Effective Inhibitors of the Influenza a Virus. Future Medicinal Chemistry 10:8, pages 851-862.
Read now
Read now
Marcio V Bertacine Dias, Jademilson C Santos, Gerardo A Libreros-Zúñiga, João A Ribeiro & Sair M Chavez-Pacheco. (2018) Folate Biosynthesis Pathway: Mechanisms and Insights into Drug Design for Infectious Diseases. Future Medicinal Chemistry 10:8, pages 935-959.
Read now
Read now
Bengt Glimelius. (2018) What Treatments Should be Skipped or Intensified in Localized Rectal Cancer?. Future Oncology 14:4, pages 313-318.
Read now
Read now
B. Glimelius & A. Martling. (2017) What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?. Acta Oncologica 56:9, pages 1139-1142.
Read now
Read now
Bengt Glimelius. (2016) What is most relevant in preoperative rectal cancer chemoradiotherapy – the chemotherapy, the radiation dose or the timing to surgery?. Acta Oncologica 55:12, pages 1381-1385.
Read now
Read now
Tayebeh Anajafi & Sanku Mallik. (2015) Polymersome-Based Drug-Delivery Strategies for Cancer Therapeutics. Therapeutic Delivery 6:4, pages 521-534.
Read now
Read now
Drew A Spencer, Jacob S Young, Deepak Kanojia, Julius W Kim, Sean P Polster, Jason P Murphy & Maciej S Lesniak. (2015) Unlocking the Promise of Oncolytic Virotherapy in Glioma: Combination With Chemotherapy to Enhance Efficacy. Therapeutic Delivery 6:4, pages 453-468.
Read now
Read now
Francesco Sclafani & David Cunningham. (2014) Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer. Future Oncology 10:14, pages 2243-2257.
Read now
Read now
Calin Radu, Ola Norrlid, Morten Brændengen, Karl Hansson, Ulf Isacsson & Bengt Glimelius. (2013) Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients. Acta Oncologica 52:3, pages 528-537.
Read now
Read now
Lene W. Vestermark, Helle A. Jensen & Per Pfeiffer. (2012) High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial. Acta Oncologica 51:3, pages 311-317.
Read now
Read now
Katrine J. Emmertsen & Søren Laurberg. (2008) Bowel dysfunction after treatment for rectal cancer. Acta Oncologica 47:6, pages 994-1003.
Read now
Read now
Articles from other publishers (76)
Ramjas Prajapati, Vikas Ostwal, Sujay Srinivas, Reena Engineer, Prabhat Bhargava, Avanish Saklani, Ashwin D’Souza, Suman Kumar, Zoya Peelay, P. Manali & Anant Ramaswamy. (2024) Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and ‘salvage’ in patients with high risk locally advanced rectal cancers – tolerance and early outcomes. Journal of Cancer Research and Therapeutics 20:1, pages 199-203.
Crossref
Crossref
Timothy O’Brien, Geke Hospers, Thierry Conroy, Heinz-Josef Lenz, Jesse Joshua Smith, Emmet Andrews, Brian O’Neill & Gregory Leonard. (2023) The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO. Irish Journal of Medical Science (1971 -).
Crossref
Crossref
Ilaria Prata, Martina Eriksson, Jasenko Krdzalic, Elma Meershoek-Klein Kranenbarg, Annet G. H. Roodvoets, Regina Beets-Tan, Cornelis J. H. van de Velde, Boudewijn van Etten, Geke A. P. Hospers, Bengt Glimelius, Per J. Nilsson, Corrie A. M. Marijnen, Koen C. M. J. Peeters & Lennart K. Blomqvist. (2023) Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control. Insights into Imaging 14:1.
Crossref
Crossref
Seda Gülbahar Ateş, Gülay Bilir Dilek & Gülin Uçmak. (2023) Primary tumor heterogeneity on pretreatment 18F-FDG PET/CT to predict outcome in patients with rectal cancer who underwent surgery after neoadjuvant therapy. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42:4, pages 223-230.
Crossref
Crossref
S. Gülbahar Ateş, G. Bilir Dilek & G. Uçmak. (2023) Heterogeneidad del tumor primario en la18F-FDG PET/TC pretratamiento para predecir el pronóstico en pacientes con cáncer de recto sometidos a cirugía tras terapia neoadyuvante. Revista Española de Medicina Nuclear e Imagen Molecular 42:4, pages 223-230.
Crossref
Crossref
Israa Imam, Klara Hammarström & Bengt Glimelius. (2023) Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study. Cancers 15:4, pages 1154.
Crossref
Crossref
Natally Horvat, Marc J. Gollub & Regina G. H. Beets-Tan. 2023. Multimodality Imaging and Intervention in Oncology. Multimodality Imaging and Intervention in Oncology
251
272
.
Gustav Alvfeldt, Peter Aspelin, Lennart Blomqvist & Nina Sellberg. (2021) Radiology reporting in rectal cancer using MRI: adherence to national template for structured reporting. Acta Radiologica 63:12, pages 1603-1612.
Crossref
Crossref
Mina Mesri, Louise Hitchman, Marina Yiaesemidou, Aaron Quyn, David Jayne & Ian Chetter. (2022) Protocol: The role of defunctioning stoma prior to neoadjuvant therapy for locally advanced colonic and rectal cancer-A systematic review. PLOS ONE 17:9, pages e0275025.
Crossref
Crossref
B Rajkrishna, Saikat Das, Dipti Masih, Tharani Putta, Rajat Raghunath & ThomasSamuel Ram. (2022) Magnetic resonance imaging downstaging, pathological response, and microsatellite instability status in patients with signet-ring cell carcinoma rectum undergoing preoperative long-course chemoradiation. Current Medical Issues 20:3, pages 154.
Crossref
Crossref
Johan Erlandsson, Stina Fuentes, Calin Radu, Jan-Erik Frödin, Hemming Johansson, Yvonne Brandberg, Torbjörn Holm, Bengt Glimelius & Anna Martling. (2021) Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial. BJS Open 5:6.
Crossref
Crossref
Artur Mezheyeuski, Patrick Micke, Alfonso Martín-Bernabé, Max Backman, Ina Hrynchyk, Klara Hammarström, Simon Ström, Joakim Ekström, Per-Henrik Edqvist, Magnus Sundström, Fredrik Ponten, Karin Leandersson, Bengt Glimelius & Tobias Sjöblom. (2021) The Immune Landscape of Colorectal Cancer. Cancers 13:21, pages 5545.
Crossref
Crossref
Israa Imam, Klara Hammarström, Tobias Sjöblom & Bengt Glimelius. (2021) Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?. Radiotherapy and Oncology 157, pages 70-77.
Crossref
Crossref
Mojca Tuta, Nina Boc, Erik Brecelj, Monika Peternel & Vaneja Velenik. (2021)
Total neoadjuvant therapy
vs
standard therapy of locally advanced rectal cancer with high-risk factors for failure
. World Journal of Gastrointestinal Oncology 13:2, pages 119-130.
Crossref
Crossref
F Jörgren, M-L Lydrup & P Buchwald. (2020) Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry. British Journal of Surgery 107:13, pages 1818-1825.
Crossref
Crossref
Lisa Hörberg, Daniel Roth, Peter Leander, Sven Månsson, Tobias Fält, Olle Ekberg & Sophia Zackrisson. (2019) Reproducibility of measurements with a semi-automatic software package for the evaluation of rectal cancer. Acta Radiologica 61:5, pages 586-594.
Crossref
Crossref
Kei Kimura, Naohito Beppu, Hiroshi Doi, Kozo Kataoka, Tomoki Yamano, Motoi Uchino, Masataka Ikeda, Hiroki Ikeuchi & Naohiro Tomita. (2020) Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer. World Journal of Gastrointestinal Oncology 12:3, pages 311-322.
Crossref
Crossref
Leandro Jimenez, Rodrigo O. Perez, Guilherme Pagin São Julião, Bruna Borba Vailati, Laura M. Fernandez, Joaquim Gama-Rodrigues, Angelita Habr-Gama, Jennifer DeVecchio, Matthew F. Kalady & Anamaria A. Camargo. (2020) Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners. Diseases of the Colon & Rectum 63:3, pages 300-309.
Crossref
Crossref
Oktar Asoglu, Handan Tokmak, Baris Bakir, Gokhan Demir, Enis Ozyar, Banu Atalar, Suha Goksel, Burak Koza, Aslihan Guven Mert, Atakan Demir & Koray Guven. (2020) The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases. European Journal of Surgical Oncology 46:3, pages 402-409.
Crossref
Crossref
G. Bregni, T. Akin Telli, S. Camera, A. Deleporte, L. Moretti, A.M. Bali, G. Liberale, S. Holbrechts, A. Hendlisz & F. Sclafani. (2020) Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice. Cancer Treatment Reviews 83, pages 101948.
Crossref
Crossref
Francesco Sclafani, Sanna Hulkki Wilson, David Cunningham, David Gonzalez De Castro, Eleftheria Kalaitzaki, Ruwaida Begum, Andrew Wotherspoon, Jaume Capdevila, Bengt Glimelius, Susana Roselló, Janet Thomas, Daina Tait, Gina Brown, Jacqui Oates & Ian Chau. (2019)
Analysis of
KRAS
,
NRAS
,
BRAF
,
PIK3CA
and
TP53
mutations in a large prospective series of locally advanced rectal cancer patients
. International Journal of Cancer 146:1, pages 94-102.
Crossref
Crossref
Hanna Abrahamsson, Alina C. Porojnicu, Jonas C. Lindstrøm, Svein Dueland, Kjersti Flatmark, Knut H. Hole, Therese Seierstad, Johan Moan, Kathrine Røe Redalen, Sebastian Meltzer & Anne Hansen Ree. (2019) High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer. BMC Cancer 19:1.
Crossref
Crossref
Marc J. Gollub, Chandana Lall, Neeraj Lalwani & Michael H. Rosenthal. (2019) Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI. Abdominal Radiology 44:11, pages 3549-3558.
Crossref
Crossref
P. Yu. Grishko, A. V. Mishchenko, Y. A. Grinfeld, D. V. Samsonov & A. M. Karachun. (2019) MODERN METHODIC APPROACH FOR MRI STUDY OF RECTAL CANCER. Diagnostic radiology and radiotherapy:2, pages 102-107.
Crossref
Crossref
Anders H Elliot, Lennart Blomqvist, Arni Sigurdsson, Anna Martling, Hemming Johansson, Bengt Glimelius & Per J Nilsson. (2018) An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study. Acta Radiologica 60:8, pages 955-961.
Crossref
Crossref
J Erlandsson, D Pettersson, B Glimelius, T Holm & A Martling. (2019) Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy. British Journal of Surgery 106:9, pages 1248-1256.
Crossref
Crossref
Kevin Afshari, Abbas Chabok, Peter Naredi, Kenneth Smedh & Maziar Nikberg. (2019) Prognostic factors for survival in stage IV rectal cancer: A Swedish nationwide case–control study. Surgical Oncology 29, pages 102-106.
Crossref
Crossref
Johan Erlandsson, Ester Lörinc, Madelene Ahlberg, David Pettersson, Torbjörn Holm, Bengt Glimelius & Anna Martling. (2019) Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial. Radiotherapy and Oncology 135, pages 178-186.
Crossref
Crossref
Manuel Campos de Gouveia & Laura Elisabete Ribeiro Barbosa. (2019) Timing of neoadjuvant therapy and surgical treatment in rectal cancer. Journal of Coloproctology 39:2, pages 178-183.
Crossref
Crossref
Georges Tinawi, Ashok Gunawardene, Ali Shekouh, Peter D. Larsen & Elizabeth R. Dennett. (2019) Neoadjuvant therapy in rectal cancer: how are we choosing?. ANZ Journal of Surgery 89:1-2, pages 68-73.
Crossref
Crossref
Antonio Cassio Assis Pellizzon. (2019) Pre-operative radiotherapy to improve local control and survival in rectal cancer optimal time intervals between radiation and surgery. Reports of Practical Oncology & Radiotherapy 24:1, pages 1-2.
Crossref
Crossref
Bengt Glimelius. 2019. Comprehensive Rectal Cancer Care. Comprehensive Rectal Cancer Care
335
353
.
Mit Dattani & Gina Brown. 2019. Fundamentals of Anorectal Surgery. Fundamentals of Anorectal Surgery
359
389
.
Klara Hammarström, Artur Mezheyeuski, Nafsika Korsavidou Hult, Tobias Sjöblom & Bengt Glimelius. (2018) Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers. European Journal of Surgical Oncology 44:12, pages 1858-1864.
Crossref
Crossref
Campbell S. Roxburgh & Martin R. Weiser. (2018) Selective use of radiation for locally advanced rectal cancer: one size does not fit all. Minerva Chirurgica 73:6.
Crossref
Crossref
Xin Wang, Yongyang Yu, Wenjian Meng, Dan Jiang, Xiangbing Deng, Bing Wu, Hua Zhuang, Cun Wang, Yali Shen, Lie Yang, Hong Zhu, Ke Cheng, Yaqin Zhao, Zhiping Li, Memg Qiu, Hongfeng Gou, Feng Bi, Feng Xu, Rrenmin Zhong, Sen Bai, Ziqiang Wang & Zongguang Zhou. (2018) Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial. Radiotherapy and Oncology 129:2, pages 300-305.
Crossref
Crossref
Takahiro Hiratsuka, Tsuyoshi Etoh, Takao Hara, Tomonori Akagi, Koichiro Tahara, Toshifumi Matsumoto, Tadashi Ogawa, Kyuzo Fujii, Akio Shiromizu, Hidefumi Shiroshita & Masafumi Inomata. (2018) Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study. Journal of the Anus, Rectum and Colon 2:4, pages 168-175.
Crossref
Crossref
Natally Horvat, Iva Petkovska & Marc J. Gollub. (2018) MR Imaging of Rectal Cancer. Radiologic Clinics of North America 56:5, pages 751-774.
Crossref
Crossref
Morten Brændengen & Bengt Glimelius. (2018) Preoperative radiotherapy or chemoradiotherapy in rectal cancer – Is survival improved? An update of the “Nordic” LARC study in non-resectable cancers. Radiotherapy and Oncology 127:3, pages 392-395.
Crossref
Crossref
M. Dattani, C. Marijnen, B. Moran, D. Tait, C. Cunningham, M. Rodriguez‐Bigas & G. Brown. (2018) Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?. Colorectal Disease 20:S1, pages 92-96.
Crossref
Crossref
Francesco Sclafani, Ian Chau, David Cunningham, Jens C. Hahne, George Vlachogiannis, Zakaria Eltahir, Andrea Lampis, Chiara Braconi, Eleftheria Kalaitzaki, David Gonzalez De Castro, Andrew Wotherspoon, Jaume Capdevila, Bengt Glimelius, Noelia Tarazona, Ruwaida Begum, Hazel Lote, Sanna Hulkki Wilson, Giulia Mentrasti, Gina Brown, Diana Tait, Jacqueline Oates & Nicola Valeri. (2018) KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Scientific Reports 8:1.
Crossref
Crossref
G. P. São Julião, A. Habr-Gama, B. B. Vailati & R. O. Perez. (2017) The good, the bad and the ugly: rectal cancers in the twenty-first century. Techniques in Coloproctology 21:7, pages 573-575.
Crossref
Crossref
Francesco Sclafani, Gina Brown, David Cunningham, Sheela Rao, Paris Tekkis, Diana Tait, Federica Morano, Chiara Baratelli, Eleftheria Kalaitzaki, Shahnawaz Rasheed, David Watkins, Naureen Starling, Andrew Wotherspoon & Ian Chau. (2017) Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy. The Oncologist 22:6, pages 728-736.
Crossref
Crossref
Johan Erlandsson & Anna Martling. (2017) Short-course radiotherapy with delayed surgery for rectal cancer – Authors' reply. The Lancet Oncology 18:6, pages e295.
Crossref
Crossref
Johan Erlandsson, Torbjörn Holm, David Pettersson, Åke Berglund, Björn Cedermark, Calin Radu, Hemming Johansson, Mikael Machado, Fredrik Hjern, Olof Hallböök, Ingvar Syk, Bengt Glimelius & Anna Martling. (2017) Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. The Lancet Oncology 18:3, pages 336-346.
Crossref
Crossref
Q. Denost, C. Kontovounisios, S. Rasheed, R. Chevalier, R. Brasio, M. Capdepont, E. Rullier & P.P. Tekkis. (2017) Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer. European Journal of Surgical Oncology (EJSO) 43:1, pages 92-99.
Crossref
Crossref
S. Hasegawa, R. Takahashi, K. Hida, K. Kawada & Y. Sakai. (2016) Revisiting the treatment strategy for rectal cancer through the pattern of local recurrence. European Journal of Surgical Oncology (EJSO) 42:11, pages 1674-1679.
Crossref
Crossref
Francesco Sclafani & Ian Chau. (2016) Timing of Therapies in the Multidisciplinary Treatment of Locally Advanced Rectal Cancer: Available Evidence and Implications for Routine Practice. Seminars in Radiation Oncology 26:3, pages 176-185.
Crossref
Crossref
Claudio V. Sole, Felipe A. Calvo, Emilio Alvarez & Jose L. Carreras. (2016) Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy. European Journal of Nuclear Medicine and Molecular Imaging 43:8, pages 1444-1452.
Crossref
Crossref
Wen-Hua Fan, Fu-Long Wang, Zhen-Hai Lu, Zhi-Zhong Pan, Li-Ren Li, Yuan-Hong Gao, Gong Chen, Xiao-Jun Wu, Pei-Rong Ding, Zhi-Fan Zeng & De-Sen Wan. (2015) Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial. Chinese Journal of Cancer 34:3.
Crossref
Crossref
Naohito Beppu, Masayoshi Kobayashi, Nagahide Matsubara, Masashi Noda, Tomoki Yamano, Hiroshi Doi, Norihiko Kamikonya, Ayako Kakuno, Fumihiko Kimura, Naoki Yamanaka, Hidenori Yanagi & Naohiro Tomita. (2015) Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer. International Journal of Colorectal Disease 30:10, pages 1339-1347.
Crossref
Crossref
Linda Ferrari & Alessandro Fichera. (2015) Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer. Gastroenterology Report, pages gov039.
Crossref
Crossref
Naohito Beppu, Nagahide Matsubara, Masashi Noda, Tomoki Yamano, Ayako Kakuno, Hiroshi Doi, Norihiko Kamikonya, Fumihiko Kimura, Naoki Yamanaka, Hidenori Yanagi & Naohiro Tomita. (2015) Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer. Surgery 158:1, pages 225-235.
Crossref
Crossref
J. Joshua SmithJulio Garcia-Aguilar. (2015) Advances and Challenges in Treatment of Locally Advanced Rectal Cancer. Journal of Clinical Oncology 33:16, pages 1797-1808.
Crossref
Crossref
Claudio V. Sole, Felipe A. Calvo, Carlos Ferrer, Emilio Alvarez, Jose L. Carreras & Enrique Ochoa. (2014) Human cytomegalovirus and Epstein-Barr virus infection impact on 18F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy. European Journal of Nuclear Medicine and Molecular Imaging 42:2, pages 186-196.
Crossref
Crossref
A.H. Elliot, A. Martling, B. Glimelius, C. Nordenvall, H. Johansson & P.J. Nilsson. (2014) Preoperative treatment selection in rectal cancer: A population-based cohort study. European Journal of Surgical Oncology (EJSO) 40:12, pages 1782-1788.
Crossref
Crossref
John P. Plastaras, Francesco Dionisi & Jennifer Y. Wo. (2014) Gastrointestinal Cancer. The Cancer Journal 20:6, pages 378-386.
Crossref
Crossref
Bengt Glimelius. (2014) Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?. Frontiers in Oncology 4.
Crossref
Crossref
Marie-Luise Sautter-Bihl, Werner Hohenberger, Rainer Fietkau, Claus Roedel, Heinz Schmidberger & Rolf Sauer. (2013) MRI-Based Treatment of Rectal Cancer: Is Prognostication of the Recurrence Risk Solid Enough to Render Radiation Redundant?. Annals of Surgical Oncology 21:1, pages 197-204.
Crossref
Crossref
Per J Nilsson, Boudewijn van Etten, Geke AP Hospers, Lars Påhlman, Cornelis JH van de Velde, Regina GH Beets-Tan, Lennart Blomqvist, Jannet C Beukema, Ellen Kapiteijn, Corrie AM Marijnen, Iris D Nagtegaal, Theo Wiggers & Bengt Glimelius. (2013) Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial. BMC Cancer 13:1.
Crossref
Crossref
Claudio V. Sole, Felipe A. Calvo, Emilio Alvarez, Isabel Peligros, Pilar Garcia-Alfonso, Carlos Ferrer, Enrique Ochoa, Rafael Herranz & Jose L. Carreras. (2013) Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy. European Journal of Nuclear Medicine and Molecular Imaging 40:11, pages 1635-1644.
Crossref
Crossref
Felipe A. Calvo, Claudio V. Sole, Dolores de la Mata, Luis Cabez?n, Marina G?mez-Esp?Emilio Alvarez, Paz Madariaga & Jos? L. Carreras. (2013) 18F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes. European Journal of Nuclear Medicine and Molecular Imaging 40:5, pages 657-667.
Crossref
Crossref
Angelita Habr-Gama, Joaquim Gama-Rodrigues & Rodrigo Oliva Perez. (2013) Is Tailoring Treatment of Rectal Cancer the Only True Benefit of Long-Course Neoadjuvant Chemoradiation?. Diseases of the Colon & Rectum 56:2, pages 264-266.
Crossref
Crossref
D. Asplund, E. Haglind & E. Angenete. (2012) Outcome of extralevator abdominoperineal excision compared with standard surgery: results from a single centre. Colorectal Disease 14:10, pages 1191-1196.
Crossref
Crossref
Fredrik Jörgren, Mef Nilbert, Eva Rambech, Pär-Ola Bendahl & Gudrun Lindmark. (2012) Ezrin expression in rectal cancer predicts time to development of local recurrence. International Journal of Colorectal Disease 27:7, pages 893-899.
Crossref
Crossref
Lauren Kosinski, Angelita Habr‐Gama, Kirk Ludwig & Rodrigo Perez. (2012) Shifting concepts in rectal cancer management. CA: A Cancer Journal for Clinicians 62:3, pages 173-202.
Crossref
Crossref
Eliane C.M. Zeestraten, Peter J.K. Kuppen, Cornelis J.H. van de Velde & Corrie A.M. Marijnen. (2012) Prediction in Rectal Cancer. Seminars in Radiation Oncology 22:2, pages 175-183.
Crossref
Crossref
Krzysztof Bujko. 2012. Multidisciplinary Management of Rectal Cancer. Multidisciplinary Management of Rectal Cancer
149
154
.
Jasper Nijkamp, Karin Haustermans & Corrie A. M. Marijnen. 2012. Multidisciplinary Management of Rectal Cancer. Multidisciplinary Management of Rectal Cancer
129
148
.
Paul Rooney & Nagarajan Pranesh. 2012. Contemporary Coloproctology. Contemporary Coloproctology
173
186
.
Bodil Ginnerup PedersenBrendan MoranGina BrownLennart BlomqvistMorten Fenger-GrønSøren Laurberg. (2011) Reproducibility of Depth of Extramural Tumor Spread and Distance to Circumferential Resection Margin at Rectal MRI: Enhancement of Clinical Guidelines for Neoadjuvant Therapy. American Journal of Roentgenology 197:6, pages 1360-1366.
Crossref
Crossref
Morten Brændengen, Karl Hansson, Calin Radu, Albert Siegbahn, Hans Jacobsson & Bengt Glimelius. (2011) Delineation of Gross Tumor Volume (GTV) for Radiation Treatment Planning of Locally Advanced Rectal Cancer Using Information From MRI or FDG-PET/CT: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics 81:4, pages e439-e445.
Crossref
Crossref
Bengt Glimelius, Regina Beets-Tan, Lennart Blomqvist, Gina Brown, Iris Nagtegaal, Lars Påhlman, Phil Quirke, Vincenzo Valentini & Cornelis van de Velde. (2011) Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer. Journal of Clinical Oncology 29:16, pages 2142-2143.
Crossref
Crossref
Yong Ki SohnJin Yong ShinKwan Hee Hong. (2010) Prognostic Analysis According to N Stage and Circumferential Resection Margin in Patients with Locally Advanced Rectal Cancer. Journal of the Korean Society of Coloproctology 26:3, pages 217.
Crossref
Crossref
Morten BrændengenKjell M. TveitÅke BerglundElke BirkemeyerGunilla FrykholmLars PåhlmanJohan N. WiigPer ByströmKrzysztof BujkoBengt Glimelius. (2008) Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. Journal of Clinical Oncology 26:22, pages 3687-3694.
Crossref
Crossref
H Birgisson, L Påhlman, U Gunnarsson & B Glimelius. (2008)
Authors' reply: Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy (
Br J Surg
2008; 95: 206–213)
. British Journal of Surgery 95:6, pages 803-803.
Crossref
Crossref